Product Information
LACOSAMIDE 50 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1153 per EA under NDC 65862074760. Its NADAC has been published 111 times since Jul 10, 2024.
FDA first approved this application on Jan 5, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862074760
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LACOSAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204994FDA Approved
1/5/2023
TE Code
AB
On Market Since
1/5/2023
Pharmacological Classes
Price Statistics
The NADAC for LACOSAMIDE 50 MG TABLET has been published 111 times since Jul 10, 2024, and over the history we have for it it has declined 31.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1153 per EA |
|---|---|
| All-time high | $0.1878 (Sep 11, 2024) |
| All-time low | $0.1045 (Nov 20, 2024) |
| 52-week high | $0.1359 |
| 52-week low | $0.1046 |
| Median price | $0.1358 |
| Average price | $0.1343 |
| Largest weekly change | +38.3% (Aug 21, 2024) |
| Weeks tracked | 111 |
| Tracking since | Jul 10, 2024 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LACOSAMIDE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LACOSAMIDE 50 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.1153 per EA (NDC 65862074760), effective Aug 19, 2026.
How has the price of LACOSAMIDE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for LACOSAMIDE 50 MG TABLET has declined 31.8%. It has been tracked across 111 weekly CMS publications since Jul 10, 2024.
What are the highest and lowest recorded NADAC prices for LACOSAMIDE 50 MG TABLET?
Since Jul 10, 2024, the NADAC for LACOSAMIDE 50 MG TABLET has ranged from a low of $0.1045 (Nov 20, 2024) to a high of $0.1878 (Sep 11, 2024), with a median of $0.1358 per EA.
Are there cheaper alternatives to LACOSAMIDE 50 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LACOSAMIDE 50 MG TABLET, is $0.1061 per EA — about 8% below LACOSAMIDE 50 MG TABLET.
Who manufactures LACOSAMIDE 50 MG TABLET?
LACOSAMIDE 50 MG TABLET (NDC 65862074760) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.